These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 15735037)

  • 1. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
    Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
    Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
    Zhou G; Liu X; Li Y; Xu S; Ma C; Wu X; Cheng Y; Yu Z; Zhao G; Chen Y
    Oncotarget; 2016 Mar; 7(12):14925-39. PubMed ID: 26908447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of acridine-based telomerase inhibition and telomere shortening.
    Gunaratnam M; Greciano O; Martins C; Reszka AP; Schultes CM; Morjani H; Riou JF; Neidle S
    Biochem Pharmacol; 2007 Sep; 74(5):679-89. PubMed ID: 17631279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of Telomere G-Quadruplexes Interferes with Human Herpesvirus 6A Chromosomal Integration.
    Gilbert-Girard S; Gravel A; Artusi S; Richter SN; Wallaschek N; Kaufer BB; Flamand L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism.
    Phatak P; Cookson JC; Dai F; Smith V; Gartenhaus RB; Stevens MF; Burger AM
    Br J Cancer; 2007 Apr; 96(8):1223-33. PubMed ID: 17406367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity.
    Gowan SM; Harrison JR; Patterson L; Valenti M; Read MA; Neidle S; Kelland LR
    Mol Pharmacol; 2002 May; 61(5):1154-62. PubMed ID: 11961134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor.
    Incles CM; Schultes CM; Kelland LR; Neidle S
    Mol Pharmacol; 2003 Nov; 64(5):1101-8. PubMed ID: 14573759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
    Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
    J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
    Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
    Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells.
    Incles CM; Schultes CM; Kempski H; Koehler H; Kelland LR; Neidle S
    Mol Cancer Ther; 2004 Oct; 3(10):1201-6. PubMed ID: 15486186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel Schizocommunin Derivatives as Telomeric G-Quadruplex Ligands That Trigger Telomere Dysfunction and the Deoxyribonucleic Acid (DNA) Damage Response.
    Che T; Chen SB; Tu JL; Wang B; Wang YQ; Zhang Y; Wang J; Wang ZQ; Zhang ZP; Ou TM; Zhao Y; Tan JH; Huang ZS
    J Med Chem; 2018 Apr; 61(8):3436-3453. PubMed ID: 29618208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRACO19 analog dimers with improved inhibition of telomerase and hPot 1.
    Fu YT; Keppler BR; Soares J; Jarstfer MB
    Bioorg Med Chem; 2009 Mar; 17(5):2030-7. PubMed ID: 19201200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration.
    Gomez D; Aouali N; Londoño-Vallejo A; Lacroix L; Mégnin-Chanet F; Lemarteleur T; Douarre C; Shin-ya K; Mailliet P; Trentesaux C; Morjani H; Mergny JL; Riou JF
    J Biol Chem; 2003 Dec; 278(50):50554-62. PubMed ID: 14525974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes.
    Gowan SM; Heald R; Stevens MF; Kelland LR
    Mol Pharmacol; 2001 Nov; 60(5):981-8. PubMed ID: 11641426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells.
    Brassart B; Gomez D; De Cian A; Paterski R; Montagnac A; Qui KH; Temime-Smaali N; Trentesaux C; Mergny JL; Gueritte F; Riou JF
    Mol Pharmacol; 2007 Sep; 72(3):631-40. PubMed ID: 17586599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
    Taka T; Huang L; Wongnoppavich A; Tam-Chang SW; Lee TR; Tuntiwechapikul W
    Bioorg Med Chem; 2013 Feb; 21(4):883-90. PubMed ID: 23321015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-quadruplexes as therapeutic targets.
    Neidle S; Read MA
    Biopolymers; 2000-2001; 56(3):195-208. PubMed ID: 11745111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
    Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
    Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.